Abstracts

Innate Sensing and Signaling to HIV-1 in Dendritic Cells

Dendritic cells (DCs) are central players in the induction of innate and adaptive immunity to HIV-1. Innate sensing of pathogens by pattern recognition receptors (PRRs) triggers signaling pathways that lead to the induction of DC maturation, antiviral type I IFN responses and cytokine responses, and subsequent induction of specific T helper cell differentiation and adaptive…

How HIV-1 Evades DNA Sensors

Retroviruses must replicate their genomes in the presence of cytosolic DNA sensors capable of triggering an antiviral response. Here we demonstrate that HIV-1 reverse transcribed DNA products are shielded from cytosolic DNA sensors by the HIV-1 core. Treatment of HIV-1 infected cells with the capsid-binding drug PF-3450074 releases DNA products into the cytosol where they…

HIV Phylogenetics: Lessons for HIV Prevention

HIV phylogenetics, the study of viral genetic sequences, is used to track the spread of different viral lineages, and to identify likely transmission events, chains and clusters. Phylogenetics enhances HIV prevention science by quantifying the risk factors for onwards transmission, resolving epidemics into sub-epidemics, and identifying common routes of transmission. In discordant pair studies, such…

Criminalizing HIV: Recent Experience in the United States and Africa to Update Laws and Policies to Promote the Public Health

Laws and policies have been used to protect people living with HIV and affected communities from stigma and discrimination. Indeed, the Americans with Disabilities Act (ADA) and the UN Convention on the Rights of Persons with Disabilities are just two legal instruments that help to create environments where people feel safe enough to come forward…

Advances in Mycobacterial Diagnostics

The past 10 years have seen rapid advances in mycobacterial diagnostics. Specifically, nucleic acid amplification testing has been validated and widely implemented for both TB diagnosis and for identification of resistance to first and second line anti-TB drugs. The World Health Organization has recommended use of Xpert MTB/RIF (Xpert) as the initial diagnostic test for…

New Medications, Innovative Approaches: Accelerate the TB Regimen Development Pipeline

This is an exciting time for tuberculosis drug development with a number of clinical trials reporting (REFAQUIN, OFLOTUB, REMoxTB). The challenge facing drug development is illustrated by the flouroquinolones trials to prove the promising results in Phase 2 regimens. It is time that we review drug development methodologies critically. The dizzying number of potential dosages…

Tuberculosis in Pregnancy

Tuberculosis (TB) is a major cause of morbidity and mortality in women of childbearing age (15 to 44 years), accounting for almost 400,000 deaths in this age group every year. Pregnancy and HIV co-infection increase the likelihood that women with latent TB infection (LTBI) will progress to active TB disease, which raises the risk of…

Tuberculosis in Children

This presentation will include an overview of the global epidemiology of tuberculosis in children, including the impact of HIV, and with specific emphasis on emerging data on drug-resistant TB. Data will be presented on the historical challenges of evaluating existing and novel treatment strategies for TB in children. Emerging research opportunities and key early findings…